Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


11 Ann Intern Med
1 Antiviral Res
2 Arch Virol
2 Cell
5 Epidemiol Infect
3 J Epidemiol Community Health
1 J Exp Med
7 J Infect Dis
3 J Virol
1 Lancet
5 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
6 PLoS Comput Biol
47 PLoS One
8 Proc Natl Acad Sci U S A
4 Vaccine
3 Virology
2 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. SASSA MH, Harada KH
    Serodiagnostics for SARS-CoV-2.
    Ann Intern Med. 2021;174:287.

  2. DUNNE C, Lang E
    In adults hospitalized with COVID-19, the quick COVID-19 Severity Index predicted 24-h respiratory decompensation.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/ACPJ202102160.
    PubMed         Abstract available

    The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/ACPJ202102160.
    PubMed         Abstract available

  4. ORAN DP, Topol EJ
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:286-287.

  5. COHEN AN, Kessel B
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:284-285.

  6. CEVIK M, Bogoch II, Carson G, D'Ortenzio E, et al
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:283-284.

    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:283.

  8. HAN D, Li J
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:284.

  9. AKILLI NB, Koylu R
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:286.

  10. ELDER C
    Prevalence of Asymptomatic SARS-CoV-2 Infection.
    Ann Intern Med. 2021;174:285-286.

  11. PAPENBURG J, Yansouni CP, Caya C, Cheng MP, et al
    Serodiagnostics for SARS-CoV-2.
    Ann Intern Med. 2021;174:287-288.

    Antiviral Res

  12. PATEL MC, Chesnokov A, Jones J, Mishin VP, et al
    Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
    Antiviral Res. 2021;188:105035.
    PubMed         Abstract available

    Arch Virol

  13. TSUNEKI-TOKUNAGA A, Kanai K, Itagaki A, Tsuchie H, et al
    Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04976.
    PubMed         Abstract available

  14. YANG F, Xiao Y, Liu F, Yao H, et al
    Isolation and characterization of two novel reassortant H5N6 avian influenza viruses from waterfowl in eastern China.
    Arch Virol. 2021 Feb 17. pii: 10.1007/s00705-021-04995.
    PubMed         Abstract available


  15. ALTMANN DM, Boyton RJ
    Decoding the unknowns in long covid.
    BMJ. 2021;372:n132.

    Patient participation groups could provide huge voluntary support to the NHS.
    BMJ. 2021;372:n279.

  17. SPENCER NJ, Fryer AA, Farmer AD, Duff CJ, et al
    Blood test monitoring of immunomodulatory therapy in inflammatory disease.
    BMJ. 2021;372:n159.

  18. KNIPE D, Hawton K, Siynor M, Niederkrotenthaler T, et al
    Researchers must contribute to responsible reporting of suicide.
    BMJ. 2021;372:n351.

  19. BAKER MG, Wilson N, Blakely T
    Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.
    BMJ. 2020;371:m4907.

  20. CARR A, Smith JA, Camaradou J, Prieto-Alhambra D, et al
    Growing backlog of planned surgery due to covid-19.
    BMJ. 2021;372:n339.

  21. MARTEAU TM, Rutter H, Marmot M
    Changing behaviour: an essential component of tackling health inequalities.
    BMJ. 2021;372:n332.

  22. BELL KJL, Glasziou P, Stanaway F, Bossuyt P, et al
    Equity and evidence during vaccine rollout: stepped wedge cluster randomised trials could help.
    BMJ. 2021;372:n435.


  23. NIE X, Qian L, Sun R, Huang B, et al
    Multi-organ proteomic landscape of COVID-19 autopsies.
    Cell. 2021;184:775-791.
    PubMed         Abstract available

  24. ATYEO C, Pullen KM, Bordt EA, Fischinger S, et al
    Compromised SARS-CoV-2-specific placental antibody transfer.
    Cell. 2021;184:628-642.
    PubMed         Abstract available

    Epidemiol Infect

  25. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    PubMed         Abstract available

  26. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    PubMed         Abstract available

  27. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    PubMed         Abstract available

  28. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    PubMed         Abstract available

  29. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    PubMed         Abstract available

    J Epidemiol Community Health

  30. KONTOPANTELIS E, Mamas MA, Deanfield J, Asaria M, et al
    Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.
    J Epidemiol Community Health. 2021;75:213-223.
    PubMed         Abstract available

  31. OYEBODE O, Ramsay SE, Brayne C
    Public health research in the UK to understand and mitigate the impact of COVID-19 and COVID-19 response measures.
    J Epidemiol Community Health. 2021;75:209-212.
    PubMed         Abstract available

  32. NIEDZWIEDZ CL, Green MJ, Benzeval M, Campbell D, et al
    Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study.
    J Epidemiol Community Health. 2021;75:224-231.
    PubMed         Abstract available

    J Exp Med

  33. BASTARD P, Michailidis E, Hoffmann HH, Chbihi M, et al
    Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
    J Exp Med. 2021;218.
    PubMed         Abstract available

    J Infect Dis

  34. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
    J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
    PubMed         Abstract available

  35. UUSITUPA E, Waris M, Heikkinen T
    Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:298-304.
    PubMed         Abstract available

  36. THIELEN BK, Bye E, Wang X, Maroushek S, et al
    Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.
    J Infect Dis. 2020;222:288-297.
    PubMed         Abstract available

  37. SEPPALA EM, Oikarinen S, Lehtonen JP, Neupane S, et al
    Association of Picornavirus Infections With Acute Otitis Media in a Prospective Birth Cohort Study.
    J Infect Dis. 2020;222:324-332.
    PubMed         Abstract available

  38. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Reply to Li et al.
    J Infect Dis. 2020;222:696-698.

  39. MOHKHEDKAR M, Venigalla SSK, Janakiraman V
    Autoantigens That May Explain Postinfection Autoimmune Manifestations in Patients With Coronavirus Disease 2019 Displaying Neurological Conditions.
    J Infect Dis. 2021;223:536-537.

  40. DAI M, Li H, Yan N, Huang J, et al
    Long-term Survival of SARS-CoV-2 on Salmon as a Source for International Transmission.
    J Infect Dis. 2021;223:537-539.

    J Virol

  41. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    PubMed         Abstract available

  42. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    PubMed         Abstract available

  43. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    PubMed         Abstract available


  44. MALANI PN, Golub RM
    Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19.
    JAMA. 2021 Jan 21. pii: 2775645. doi: 10.1001/jama.2021.0585.

  45. RUBIN R
    Helping People Who Are Homeless Stay Healthy During the Pandemic.
    JAMA. 2021;325:517-519.

  46. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.

  47. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.

  48. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.

  49. MEHROTRA A, Bhatia RS, Snoswell CL
    Paying for Telemedicine After the Pandemic.
    JAMA. 2021;325:431-432.

  50. ABBASI J
    Predicting COVID-19 Outcomes in Emergency Department Patients.
    JAMA. 2021;325:522.

  51. ABBASI J
    CRISPR-Based COVID-19 Smartphone Test in Development.
    JAMA. 2021;325:522.

  52. ESCALANTE E, Golden RL, Mason DJ
    Social Isolation and Loneliness: Imperatives for Health Care in a Post-COVID World.
    JAMA. 2021;325:520-521.

  53. TAN IB, Tan C, Hsu LY, Dan YY, et al
    Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore.
    JAMA. 2021;325:584-585.

    Donning and Doffing.
    JAMA. 2021;325:536.

  55. NARAYAN KMV, Curran JW, Foege WH
    The COVID-19 Pandemic as an Opportunity to Ensure a More Successful Future for Science and Public Health.
    JAMA. 2021;325:525-526.


  56. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.

    MMWR Morb Mortal Wkly Rep

  57. COVID-19 Stats: Percentage of Middle and High School Students Aged 13-21 Years Attending In-Person Classes Who Reported Observing Fellow Students Wearing a Mask All the Time,* by School Setting and Activity - United States, October 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:223.

  58. BILLOCK RM, Groenewold MR, Free H, Haring Sweeney M, et al
    Required and Voluntary Occupational Use of Hazard Controls for COVID-19 Prevention in Non-Health Care Workplaces - United States, June 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:250-253.
    PubMed         Abstract available

  59. HONG K, Zhou F, Tsai Y, Jatlaoui TC, et al
    Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:245-249.
    PubMed         Abstract available

  60. DEMEKE HB, Merali S, Marks S, Pao LZ, et al
    Trends in Use of Telehealth Among Health Centers During the COVID-19 Pandemic - United States, June 26-November 6, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:240-244.
    PubMed         Abstract available

  61. BROOKS JT, Beezhold DH, Noti JD, Coyle JP, et al
    Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:254-257.
    PubMed         Abstract available

    N Engl J Med

  62. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
    N Engl J Med. 2021;384:e32.

    PLoS Comput Biol

  63. OMAR SI, Zhao M, Sekar RV, Moghadam SA, et al
    Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.
    PLoS Comput Biol. 2021;17:e1008603.
    PubMed         Abstract available

  64. BIN M, Cheung PYK, Crisostomi E, Ferraro P, et al
    Post-lockdown abatement of COVID-19 by fast periodic switching.
    PLoS Comput Biol. 2021;17:e1008604.
    PubMed         Abstract available

  65. TEPEKULE B, Hauser A, Kachalov VN, Andresen S, et al
    Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19.
    PLoS Comput Biol. 2021;17:e1008609.
    PubMed         Abstract available

  66. DATTNER I, Goldberg Y, Katriel G, Yaari R, et al
    The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children.
    PLoS Comput Biol. 2021;17:e1008559.
    PubMed         Abstract available

  67. BRACHER J, Ray EL, Gneiting T, Reich NG, et al
    Evaluating epidemic forecasts in an interval format.
    PLoS Comput Biol. 2021;17:e1008618.
    PubMed         Abstract available

  68. KOYAMA S, Horie T, Shinomoto S
    Estimating the time-varying reproduction number of COVID-19 with a state-space method.
    PLoS Comput Biol. 2021;17:e1008679.
    PubMed         Abstract available

    PLoS One

  69. KUNZLER AM, Stoffers-Winterling J, Stoll M, Mancini AL, et al
    Mental health and psychosocial support strategies in highly contagious emerging disease outbreaks of substantial public concern: A systematic scoping review.
    PLoS One. 2021;16:e0244748.
    PubMed         Abstract available

  70. KO K, Nagashima S, E B, Ouoba S, et al
    Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.
    PLoS One. 2021;16:e0246383.
    PubMed         Abstract available

  71. XIA L, He G, Feng Y, Yu X, et al
    COVID-19 associated anxiety enhances tinnitus.
    PLoS One. 2021;16:e0246328.
    PubMed         Abstract available

  72. HENNEIN R, Mew EJ, Lowe SR
    Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
    PLoS One. 2021;16:e0246602.
    PubMed         Abstract available

  73. NEMETH L, Jdanov DA, Shkolnikov VM
    An open-sourced, web-based application to analyze weekly excess mortality based on the Short-term Mortality Fluctuations data series.
    PLoS One. 2021;16:e0246663.
    PubMed         Abstract available

  74. ABOU-ARAB O, Beyls C, Khalipha A, Guilbart M, et al
    Microvascular flow alterations in critically ill COVID-19 patients: A prospective study.
    PLoS One. 2021;16:e0246636.
    PubMed         Abstract available

  75. WAKITA M, Idei M, Saito K, Horiuchi Y, et al
    Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests.
    PLoS One. 2021;16:e0246536.
    PubMed         Abstract available

  76. BUKAUSKAS A, Koronaki A, Lee TU, Ott D, et al
    Curved-crease origami face shields for infection control.
    PLoS One. 2021;16:e0245737.
    PubMed         Abstract available

  77. ALEMANNO F, Houdayer E, Parma A, Spina A, et al
    COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience.
    PLoS One. 2021;16:e0246590.
    PubMed         Abstract available

  78. BISH DR, Bish EK, El-Hajj H, Aprahamian H, et al
    A robust pooled testing approach to expand COVID-19 screening capacity.
    PLoS One. 2021;16:e0246285.
    PubMed         Abstract available

  79. RAD FA, Otaki F, Baqain Z, Zary N, et al
    Rapid transition to distance learning due to COVID-19: Perceptions of postgraduate dental learners and instructors.
    PLoS One. 2021;16:e0246584.
    PubMed         Abstract available

  80. MONTRUCCHIO G, Sales G, Rumbolo F, Palmesino F, et al
    Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
    PLoS One. 2021;16:e0246771.
    PubMed         Abstract available

  81. NOH J, Danuser G
    Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide.
    PLoS One. 2021;16:e0246772.
    PubMed         Abstract available

  82. CASAS-APARICIO GA, Leon-Rodriguez I, Alvarado-de la Barrera C, Gonzalez-Navarro M, et al
    Acute kidney injury in patients with severe COVID-19 in Mexico.
    PLoS One. 2021;16:e0246595.
    PubMed         Abstract available

  83. WORKMAN AD, Jafari A, Xiao R, Bleier BS, et al
    Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
    PLoS One. 2021;16:e0244127.
    PubMed         Abstract available

  84. ONWUAMAH CK, Okwuraiwe AP, Salu OB, Shaibu JO, et al
    Comparative performance of SARS-CoV-2 real-time PCR diagnostic assays on samples from Lagos, Nigeria.
    PLoS One. 2021;16:e0246637.
    PubMed         Abstract available

  85. CHRISTOFF AP, Cruz GNF, Sereia AFR, Boberg DR, et al
    Swab pooling: A new method for large-scale RT-qPCR screening of SARS-CoV-2 avoiding sample dilution.
    PLoS One. 2021;16:e0246544.
    PubMed         Abstract available

  86. ABU-AKEL A, Spitz A, West R
    The effect of spokesperson attribution on public health message sharing during the COVID-19 pandemic.
    PLoS One. 2021;16:e0245100.
    PubMed         Abstract available

  87. DE SIO S, La Torre G, Buomprisco G, Lapteva E, et al
    Consequences of COVID19-pandemic lockdown on Italian occupational physicians' psychosocial health.
    PLoS One. 2021;16:e0243194.
    PubMed         Abstract available

  88. OLIVAS-MARTINEZ A, Cardenas-Fragoso JL, Jimenez JV, Lozano-Cruz OA, et al
    In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.
    PLoS One. 2021;16:e0245772.
    PubMed         Abstract available

  89. SERAFIM AP, Duraes RSS, Rocca CCA, Goncalves PD, et al
    Exploratory study on the psychological impact of COVID-19 on the general Brazilian population.
    PLoS One. 2021;16:e0245868.
    PubMed         Abstract available

  90. SCHNEIDER A, Kirsten H, Lordick F, Lordick F, et al
    Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?
    PLoS One. 2021;16:e0246312.
    PubMed         Abstract available

  91. GRAHAM TGW, Dugast-Darzacq C, Dailey GM, Nguyenla XH, et al
    Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection.
    PLoS One. 2021;16:e0246647.
    PubMed         Abstract available

  92. AMANN J, Sleigh J, Vayena E
    Digital contact-tracing during the Covid-19 pandemic: An analysis of newspaper coverage in Germany, Austria, and Switzerland.
    PLoS One. 2021;16:e0246524.
    PubMed         Abstract available

  93. NIELA-VILEN H, Auxier J, Ekholm E, Sarhaddi F, et al
    Pregnant women's daily patterns of well-being before and during the COVID-19 pandemic in Finland: Longitudinal monitoring through smartwatch technology.
    PLoS One. 2021;16:e0246494.
    PubMed         Abstract available

  94. HADDAWY P, Lawpoolsri S, Sa-Ngamuang C, Su Yin M, et al
    Effects of COVID-19 government travel restrictions on mobility in a rural border area of Northern Thailand: A mobile phone tracking study.
    PLoS One. 2021;16:e0245842.
    PubMed         Abstract available

  95. HUANG Q, Jackson S, Derakhshan S, Lee L, et al
    Urban-rural differences in COVID-19 exposures and outcomes in the South: A preliminary analysis of South Carolina.
    PLoS One. 2021;16:e0246548.
    PubMed         Abstract available

  96. KANTRI A, Ziati J, Khalis M, Haoudar A, et al
    Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco.
    PLoS One. 2021;16:e0246295.
    PubMed         Abstract available

  97. KRISTOFFERSEN ES, Winsvold BS, Sandset EC, Storstein AM, et al
    Experiences, distress and burden among neurologists in Norway during the COVID-19 pandemic.
    PLoS One. 2021;16:e0246567.
    PubMed         Abstract available

  98. KUN-SZABO F, Gheorghita D, Ajtai T, Hodovany S, et al
    Aerosol generation and control in the dental operatory: An in vitro spectrometric study of typical clinical setups.
    PLoS One. 2021;16:e0246543.
    PubMed         Abstract available

  99. CHIU CY, Sarwal A, Jawed M, Chemarthi VS, et al
    Telemedicine experience of NYC Internal Medicine residents during COVID-19 pandemic.
    PLoS One. 2021;16:e0246762.
    PubMed         Abstract available

  100. BRAY L, Carter B, Blake L, Saron H, et al
    "People play it down and tell me it can't kill people, but I know people are dying each day". Children's health literacy relating to a global pandemic (COVID-19); an international cross sectional study.
    PLoS One. 2021;16:e0246405.
    PubMed         Abstract available

  101. DESALEGN Z, Deyessa N, Teka B, Shiferaw W, et al
    Evaluation of COVID-19 related knowledge and preparedness in health professionals at selected health facilities in a resource-limited setting in Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0244050.
    PubMed         Abstract available

  102. PUTCHAROEN O, Wacharapluesadee S, Chia WN, Paitoonpong L, et al
    Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
    PLoS One. 2021;16:e0246864.
    PubMed         Abstract available

  103. DEJONG AF, Fish PN, Hertel J
    Running behaviors, motivations, and injury risk during the COVID-19 pandemic: A survey of 1147 runners.
    PLoS One. 2021;16:e0246300.
    PubMed         Abstract available

  104. AL-RIFAI RH, Acuna J, Al Hossany FI, Aden B, et al
    Epidemiological characterization of symptomatic and asymptomatic COVID-19 cases and positivity in subsequent RT-PCR tests in the United Arab Emirates.
    PLoS One. 2021;16:e0246903.
    PubMed         Abstract available

  105. KUPER N, Modersitzki N, Phan LV, Rauthmann J, et al
    The situation during the COVID-19 pandemic: A snapshot in Germany.
    PLoS One. 2021;16:e0245719.
    PubMed         Abstract available

  106. JERMY MC, Spence CJT, Kirton R, O'Donnell JF, et al
    Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy.
    PLoS One. 2021;16:e0246123.
    PubMed         Abstract available

  107. CHOMCZYNSKI P, Chomczynski PW, Kennedy A, Rymaszewski M, et al
    Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR.
    PLoS One. 2021;16:e0246867.
    PubMed         Abstract available

  108. MIDORIKAWA H, Aiba M, Lebowitz A, Taguchi T, et al
    Confirming validity of The Fear of COVID-19 Scale in Japanese with a nationwide large-scale sample.
    PLoS One. 2021;16:e0246840.
    PubMed         Abstract available

  109. KAFLE K, Shrestha DB, Baniya A, Lamichhane S, et al
    Psychological distress among health service providers during COVID-19 pandemic in Nepal.
    PLoS One. 2021;16:e0246784.
    PubMed         Abstract available

  110. YANG C, Chen A, Chen Y
    College students' stress and health in the COVID-19 pandemic: The role of academic workload, separation from school, and fears of contagion.
    PLoS One. 2021;16:e0246676.
    PubMed         Abstract available

  111. KATZ VS, Jordan AB, Ognyanova K
    Digital inequality, faculty communication, and remote learning experiences during the COVID-19 pandemic: A survey of U.S. undergraduates.
    PLoS One. 2021;16:e0246641.
    PubMed         Abstract available

  112. FELDMAN M, Lacey Krylova V, Farrow P, Donovan L, et al
    Community health worker knowledge, attitudes and practices towards COVID-19: Learnings from an online cross-sectional survey using a digital health platform, UpSCALE, in Mozambique.
    PLoS One. 2021;16:e0244924.
    PubMed         Abstract available

  113. MURBE D, Kriegel M, Lange J, Schumann L, et al
    Aerosol emission of adolescents voices during speaking, singing and shouting.
    PLoS One. 2021;16:e0246819.
    PubMed         Abstract available

  114. GERSHUNY J, Sullivan O, Sevilla A, Vega-Rapun M, et al
    A new perspective from time use research on the effects of social restrictions on COVID-19 behavioral infection risk.
    PLoS One. 2021;16:e0245551.
    PubMed         Abstract available

  115. DIAMOND A, Lye CT, Prasad D, Abbott D, et al
    One size does not fit all: Assuming the same normal body temperature for everyone is not justified.
    PLoS One. 2021;16:e0245257.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  116. NEANT N, Lingas G, Le Hingrat Q, Ghosn J, et al
    Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  117. AZIMI P, Keshavarz Z, Cedeno Laurent JG, Stephens B, et al
    Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  118. LI Z, Lin Y, Huang YY, Liu R, et al
    Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.

  119. EDWARDS DA, Ausiello D, Salzman J, Devlin T, et al
    Exhaled aerosol increases with COVID-19 infection, age, and obesity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  120. FAZIO RH, Ruisch BC, Moore CA, Granados Samayoa JA, et al
    Social distancing decreases an individual's likelihood of contracting COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  121. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  122. MA C, Wang J
    Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.

  123. PERRY BL, Aronson B, Pescosolido BA
    Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  124. WU MJ, Chung JR, Kim SS, Jackson ML, et al
    Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
    PubMed         Abstract available

  125. WARD BJ, Seguin A, Couillard J, Trepanier S, et al
    Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
    PubMed         Abstract available

  126. BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
    Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.

  127. HOSCHLER K, Maharjan S, Whitaker H, Southern J, et al
    Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30221.
    PubMed         Abstract available


  128. LU KT, Yamamoto T, McDonald D, Li W, et al
    U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific Rim.
    Virology. 2021;555:71-77.
    PubMed         Abstract available

  129. MORE SA, Patil AS, Sakle NS, Mokale SN, et al
    Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
    Virology. 2020;555:10-18.
    PubMed         Abstract available

  130. TAKESHITA M, Nishina N, Moriyama S, Takahashi Y, et al
    Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
    Virology. 2021;555:35-43.
    PubMed         Abstract available

    Virus Res

  131. KIM DH, Park BJ, Ahn HS, Go HJ, et al
    Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
    Virus Res. 2021 Feb 16:198342. doi: 10.1016/j.virusres.2021.198342.
    PubMed         Abstract available

  132. RIVERA-BAHENA GB, Marquez-Bandala AH, Lopez-Guerrero DV, Esquivel-Guadarrama FR, et al
    TGF-beta1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells.
    Virus Res. 2021 Feb 10:198337. doi: 10.1016/j.virusres.2021.198337.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.